0001735276-21-000021.txt : 20210226
0001735276-21-000021.hdr.sgml : 20210226
20210226160412
ACCESSION NUMBER: 0001735276-21-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poulton Jeffrey V.
CENTRAL INDEX KEY: 0001782962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 21688667
MAIL ADDRESS:
STREET 1: 300 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-02-24
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001782962
Poulton Jeffrey V.
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
151.59
2021-02-24
4
A
0
23200
0.0
A
2031-02-23
Common Stock
23200
23200
D
Represents the time-vested stock option portion of the reporting person's Annual Equity Award for 2020. The reporting person also received 12,435 performance stock units that will vest upon the achievement of four specific performance conditions, which will be reported on a Form 4 if and when each performance condition is met and the performance stock units vest.
The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Jeffrey V. Poulton
2021-02-26